Movement Disorders in Chronic Kidney Disease Patients on Hemodialysis in Mosul City

Authors

  • Omar A. Mahmood Department of Medicine, Mosul Medical College, University of Mosul, Mosul, Iraq
  • Mohammad G. Aliraqi Department of Medicine, Mosul Medical College, University of Mosul, Mosul, Iraq https://orcid.org/0000-0002-0636-5794
  • Abduladheem A. Ali Department of Biochemistry, Oncology and Nuclear Medicine Hospital, Ninevah Health Directorate, Mosul, Iraq https://orcid.org/0000-0001-9835-762X

DOI:

https://doi.org/10.3889/oamjms.2023.11278

Keywords:

Chronic kidney disease, hemodialysis., Inflammation, Calcium and phosphorus metabolism

Abstract

BACKGROUND: Movement disorders are not rare in patients with chronic kidney disease (CKD) on hemodialysis (HD). The prevalence and the exact mechanism of these disorders are unknown. Iron deficiency and dopamine dysregulation are implicated from one perspective, whereas chronic inflammation and calcium dysmetabolism may be involved from another perspective.

AIM: We studied the prevalence, delay in the diagnosis and the role of iron deficiency, inflammation, and bone abnormalities on some movement disorders in patients with CKD on HD.

METHODS: A cross-sectional study examined the prevalence, among patients with CKD on HD in Mosul city, of restless leg syndrome (RLS), periodic limb movement syndrome (PLMS), Parkinsonism, asterixis, and myoclonus. Delay in diagnosis of these disorders was also studied. Validated questionnaires and specified neurological examination were applied to define patients with these disorders. Using IBM® SPSS® v. 23 statistical software, we compared between the different groups of patients by different parameters (case–control design).

RESULTS: Among 281 enrolled CKD patients on HD in Mosul city, the prevalence of RLS, PLMS, Parkinsonism, asterixis, and myoclonus was 28.72%, 17.02%, 2.84%, 20.92%, and 24.11% respectively. Average delay in diagnoses was 2.6 (±3.09) years, 3.02 (±3.13) years, 1 (±0.78) year, 1.23 (±1.51) years, and 2.28 (±2.34) years, respectively. Median duration of dialysis in patients with PLMS and Parkinsonism tended to be higher than in those without PLMS or Parkinsonism. Neither inflammation, ferritin level nor bone dysmetabolism discriminated patients with CKD on HD with and without these movement disorders.

CONCLUSIONS: Movement disorders are prevalent in patients with CKD on HD. In Mosul city, there would be still delay in diagnosis and treatment of these movement disorders. The longer the duration on HD, the more frequent the PLMS and Parkinsonism cases.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Jabbari B, Vaziri ND. The nature, consequences, and management of neurological disorders in chronic kidney disease. Hemodial Int. 2018;22(2):150-60. https://doi.org/10.1111/hdi.12587 PMid:2879970 DOI: https://doi.org/10.1111/hdi.12587

Baumgaertel MW, Kraemer M, Berlit P. Neurologic complications of acute and chronic renal disease. In: Neurologic Aspects of Systemic Disease Part I. Vol. 119. Netherlands: Elsevier; 2014. DOI: https://doi.org/10.1016/B978-0-7020-4086-3.00024-2

Safarpour Y, Vaziri ND, Jabbari B. Movement disorders in chronic kidney disease-a descriptive review. J Stroke Cerebrovasc Dis. 2021;30(9):105408. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105408 PMid:33139171 DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105408

Kosmadakis GC, Medcalf JF. Sleep disorders in dialysis patients. Int J Artif Organs. 2008;31(11):919-27. https://doi.org/10.1177/039139880803101101 PMid:19089793 DOI: https://doi.org/10.1177/039139880803101101

Riar SK, Greenbaum LA, Bliwise DL, Leu RM. Restless legs syndrome in chronic kidney disease: Is iron or inflammatory status to blame ? J Clin Sleep Med. 2019;15(11):1629-34. https://doi.org/10.5664/jcsm.8028 PMid:31739853 DOI: https://doi.org/10.5664/jcsm.8028

Chenini S, Delaby C, Rassu AL, Barateau L, Vialaret J, Hirtz C, et al. Hepcidin and ferritin levels in restless legs syndrome: A case-control study. Sci Rep. 2020;10:11914. https://doi.org/10.1038/s41598-020-68851-0 PMid:32681031 DOI: https://doi.org/10.1038/s41598-020-68851-0

Tufekci A, Kara E. Relation of serum hepcidin levels and restless legs syndrome in chronic hemodialysis patients. Sleep Breath. 2020;25(2):897-205. https://doi.org/10.1007/s11325-020-02209-8 PMid:33029690 DOI: https://doi.org/10.1007/s11325-020-02209-8

Tsai LH, See LC, Chien CC, Chen CM, Chang SH. Risk factors for restless legs syndrome in hemodialysis patients in Taiwan. Medicine (Baltimore). 2019;98(51):e18450. https://doi.org/10.1097/MD.0000000000018450 PMid:31861018 DOI: https://doi.org/10.1097/MD.0000000000018450

Neves PD, Graciolli FG, Oliveira IB, Bridi RA, Moysés RM, Elias RM. Effect of mineral and bone metabolism on restless legs syndrome in hemodialysis patients. J Clin Sleep Med. 2017;13(1):89-94. https://doi.org/10.5664/jcsm.6396 PMid:28173916 DOI: https://doi.org/10.5664/jcsm.6396

Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, et al. Restless legs syndrome/ Willis-Ekbom disease diagnostic criteria: Updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med. 2014;15(8):860-73. https://doi.org/10.1016/j.sleep.2014.03.025 PMid:25023924 DOI: https://doi.org/10.1016/j.sleep.2014.03.025

Simakajornboon N. Periodic limb movement disorder in children. Paediatr Respir Rev. 2006;7:S55-7. https://doi.org/10.1016/j. prrv.2006.04.175 DOI: https://doi.org/10.1016/j.prrv.2006.04.175

Lesage S, Hening WA. The restless legs syndrome and periodic limb movement disorder: A review of management. Semin Neurol. 2004;24(3):249-59. https://doi.org/10.1055/s-2004-835066 PMid:15449218 DOI: https://doi.org/10.1055/s-2004-835066

Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591-601. https://doi.org/10.1002/mds.26424 PMid:26474316 DOI: https://doi.org/10.1002/mds.26424

Hamed SA. Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: Presentations, causes, and treatment strategies. Expert Rev Clin Pharmacol. 2019;12(1):61-90. https://doi.org/10.1080/17512433.2019.1555468 PMid:30501441 DOI: https://doi.org/10.1080/17512433.2019.1555468

Novak M, Winkelman JW, Unruh M. Restless legs syndrome in patients with chronic kidney disease. Semin Nephrol. 2006;35(4):347-58. https://doi.org/10.1016/j.semnephrol.2015.06.006 PMid:26355253 DOI: https://doi.org/10.1016/j.semnephrol.2015.06.006

Hamed S, Mohamed K, Elhameed SA, Moussa E, Abozaid H, Lang A, et al. Movement disorders due to selective basal ganglia lesions with uremia. Can J Neurol Sci. 2020;47(3):350-65. https://doi.org/10.1017/cjn.2020.29 PMid:32051045 DOI: https://doi.org/10.1017/cjn.2020.29

Salib M, Memon AN, Gowda AS, Rallabhandi B, Bidika E, Fayyaz H, et al. Dialysis patients with restless leg syndrome: Can we relieve their suffering ? Cureus. 2020;12(8):e10053. https://doi.org/10.7759/cureus.10053 PMid:32999776 DOI: https://doi.org/10.7759/cureus.10053

Wali SO, Alkhouli AF. Restless legs syndrome among Saudi end-stage renal disease patients on hemodialysis. Saudi Med J. 2015;36(2):204-10. https://doi.org/10.15537/smj.2015.2.10036 PMid:25719586 DOI: https://doi.org/10.15537/smj.2015.2.10036

Saraji NZ, Hami M, Boostani R, Mojahedi MJ. Restless leg syndrome in chronic hemodialysis patients in Mashhad hemodialysis centers. J Renal Inj Prev. 2017;6(2):137-41. https://doi.org/10.15171/jrip.2017.27 PMid:28497091 DOI: https://doi.org/10.15171/jrip.2017.27

Chen WC, Lim PS, Wu WC, Chiu HC, Chen CH, Kuo HY, et al. Sleep behavior disorders in a large cohort of Chinese (Taiwanese)patients maintained by long-term hemodialysis. Am J Kidney Dis. 2006;48(2):277-84. https://doi.org/10.1053/j.ajkd.2006.04.079 PMid:16860194 DOI: https://doi.org/10.1053/j.ajkd.2006.04.079

Al-Jahdali HH, Al-Qadhi WA, Khogeer HA, Al-Hejaili FF, Al-Ghamdi SM, Al Sayyari AA. Restless legs syndrome in patients on dialysis. Saudi J Kidney Dis Transpl. 2009;20(3):378-85. PMid:19414938

Nam GE, Kim NH, Han K, Choi KM, Chung HS, Kim JW, et al.

Chronic renal dysfunction, proteinuria, and risk of Parkinson’ s disease in the elderly. Mov Disord. 2019;34(8):1184-91. https://doi.org/10.1002/mds.27704 PMid:31021467 DOI: https://doi.org/10.1002/mds.27704

Lin H, Lin H, ChenYH. Increased risks of parkinsonism in the 3 years after chronic renal failure. Int J Clin Pract. 2012;66(5):499-503. https://doi.org/10.1111/j.1742-1241.2012.02896.x PMid:22452548 DOI: https://doi.org/10.1111/j.1742-1241.2012.02896.x

Chadwick D, French AT. Uraemic myoclonus: An example of reticular reflex myoclonus? J Neurol Neurosurg Psychiatry. 1979;42(1):52-5. https://doi.org/10.1136/jnnp.42.1.52 PMid:762584 DOI: https://doi.org/10.1136/jnnp.42.1.52

Downloads

Published

2023-01-08

How to Cite

1.
Mahmood OA, Aliraqi MG, Ali AA. Movement Disorders in Chronic Kidney Disease Patients on Hemodialysis in Mosul City. Open Access Maced J Med Sci [Internet]. 2023 Jan. 8 [cited 2024 Nov. 21];11(B):145-9. Available from: https://oamjms.eu/index.php/mjms/article/view/11278